There are 383 resources available
111P - Entrectinib in Chinese (mainland China, Hong Kong, Taiwan) patients (pts) with locally advanced/metastatic ROS1 fusion-positive (fp) NSCLC and NTRK-fp solid tumours
Presenter: Shun Lu
Session: Poster Display session
112P - Patient-reported outcomes (PROs) with first-line (1L) cemiplimab in patients with locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 1 subpopulation
Presenter: Igor Bondarenko
Session: Poster Display session
44P - Real-world (RW) treatment patterns, patient characteristics and outcomes in advanced non-small cell lung cancer (aNSCLC) with PD1/L1 as first-line (1L) therapy in the UK and Germany
Presenter: Michael Snee
Session: Poster Display session
45P - Pembrolizumab versus best supportive care survival outcomes in ECOG performance status 2 NSCLC patients
Presenter: Anifat Elegbede
Session: Poster Display session
46P - Prognostic impact of immune checkpoint inhibition in patients with metastatic non-small cell lung cancer (NSCLC): Real world study in central Switzerland
Presenter: Dea Allmann
Session: Poster Display session
47P - Real-world outcomes of immune checkpoint inhibitors and selective RET inhibitors for RET fusion non-small cell lung cancer
Presenter: Rui Wan
Session: Poster Display session
48P - Efficacy of osimertinib (osi) on (prevention of) bone metastases (mets) and skeletal related events (SREs) in patients (pts) with epidermal growth factor receptor mutated (EGFRm+) non-small cell lung cancer (NSCLC)
Presenter: Anita Brouns
Session: Poster Display session
49P - EGFR exon 20 insertion mutations in patients with locally advanced or metastatic NSCLC in the German prospective, CRISP Registry real-world cohort (AIO-TRK-0315)
Presenter: Frank Griesinger
Session: Poster Display session
50P - Clinical characteristics, treatment patterns and outcomes of EGFR exon 20 insertion and other EGFR mutations in Korean aNSCLC patients
Presenter: Shinkyo Yoon
Session: Poster Display session
51P - Testing patterns and outcomes of different EGFR positive metastatic non-small cell lung cancer (NSCLC) patients in a Canadian real-world setting
Presenter: Devon Boyne
Session: Poster Display session